Suppr超能文献

曲尼司特对兔角膜基质细胞培养及准分子激光原位角膜磨镶术后角膜 haze 的影响。

Effects of tranilast on cultured rabbit corneal keratocytes and corneal haze after photorefractive keratectomy.

作者信息

Okamoto S, Sakai T, Iwaki Y, Tobari I, Hamano S

机构信息

Second Department of Ophthalmology, Toho University School of Medicine, Tokyo, Japan.

出版信息

Jpn J Ophthalmol. 1999 Sep-Oct;43(5):355-62. doi: 10.1016/s0021-5155(99)00103-3.

Abstract

PURPOSE

In vitro and in vivo studies were performed to elucidate the effects of tranilast on cellular proliferation and collagen synthesis.

METHODS

Subculturing was carried out using keratocytes from rabbits that underwent photorefractive keratectomy (PRK) and developed corneal haze, and keratocytes from normal rabbit cornea.

RESULTS

Tranilast suppressed proliferation in cultured keratocytes from the corneal haze region at doses of 30 and 300 micromol/L and collagen synthesis at doses of 3, 30, and 300 micromol/L. Normal corneal cultures showed suppression of keratocyte proliferation and collagen synthesis only at a high dose of tranilast (300 micromol/L). Betamethasone suppressed proliferation of keratocytes in both haze and normal cornea at a dose of 10 micromol/L, as well as collagen synthesis at respective doses of 1 and 10 micromol/L. Diclofenac sodium suppressed collagen synthesis of keratocytes in haze cornea at a high dose of 100 micromol/L, and in keratocytes in normal cornea, at doses of 10 and 100 micromol/L. In an in vivo study, either 0.5% tranilast, 0.1% betamethasone phosphate eye drops, or a tranilast base solution (control) was instilled four times daily to rabbits that had undergone PRK. Weekly evaluation of the inhibitory effect of these drugs on the development of haze was performed 2 weeks after surgery. Tranilast suppressed haze 6-13 weeks after PRK, but betamethasone phosphate showed no effect.

CONCLUSION

These results indicate that tranilast is potentially effective for inhibiting the corneal haze that occurs after PRK.

摘要

目的

进行体外和体内研究以阐明曲尼司特对细胞增殖和胶原合成的影响。

方法

使用接受过准分子激光角膜切削术(PRK)并出现角膜混浊的兔角膜细胞以及正常兔角膜细胞进行传代培养。

结果

曲尼司特在30和300微摩尔/升剂量时抑制角膜混浊区域培养的角膜细胞增殖,在3、30和300微摩尔/升剂量时抑制胶原合成。正常角膜培养物仅在高剂量曲尼司特(300微摩尔/升)时显示角膜细胞增殖和胶原合成受到抑制。倍他米松在10微摩尔/升剂量时抑制混浊和正常角膜中的角膜细胞增殖,在1和10微摩尔/升各自剂量时抑制胶原合成。双氯芬酸钠在100微摩尔/升高剂量时抑制混浊角膜中角膜细胞的胶原合成,在10和100微摩尔/升剂量时抑制正常角膜中角膜细胞的胶原合成。在一项体内研究中,对接受过PRK的兔每天滴注4次0.5%曲尼司特、0.1%倍他米松磷酸酯滴眼液或曲尼司特碱溶液(对照)。术后2周每周评估这些药物对混浊形成的抑制作用。曲尼司特在PRK后6 - 13周抑制混浊,但倍他米松磷酸酯无作用。

结论

这些结果表明曲尼司特对抑制PRK后发生的角膜混浊可能有效。

相似文献

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验